Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-21-016063
Date:2021-05-06
Issuer: UNITED THERAPEUTICS CORP (UTHR)
Original Submission Date:

Reporting Person:

PATUSKY CHRISTOPHER
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET SILVER SPRING, MD 20910

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-06 M 2,500 a $63.90 4,800 direct
COMMON STOCK 2021-05-06 D 2,500 d $192.07 2,300 direct
COMMON STOCK 2021-05-10 S 100 d $190.52 1,200 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
SHARE TRACKING AWARD 63.9 2021-05-06 deemed execution date M 2,500 (d) 2014-06-26 2023-06-26 common stock 2,500 $63.90 9,500 direct
Footnotes
IDfootnote
f1 this exercise of share tracking awards was pursuant to a rule 10b5-1 trading plan entered into by the reporting person. share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Elevate your investments